These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9168991)

  • 1. Endogenous interleukin-1 receptor antagonist is neuroprotective.
    Loddick SA; Wong ML; Bongiorno PB; Gold PW; Licinio J; Rothwell NJ
    Biochem Biophys Res Commun; 1997 May; 234(1):211-5. PubMed ID: 9168991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
    Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
    Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist.
    Yang GY; Liu XH; Kadoya C; Zhao YJ; Mao Y; Davidson BL; Betz AL
    J Cereb Blood Flow Metab; 1998 Aug; 18(8):840-7. PubMed ID: 9701345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.
    Loddick SA; Rothwell NJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):932-40. PubMed ID: 8784237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.
    Mulcahy NJ; Ross J; Rothwell NJ; Loddick SA
    Br J Pharmacol; 2003 Oct; 140(3):471-6. PubMed ID: 12970087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
    Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causal links between brain cytokines and experimental febrile convulsions in the rat.
    Heida JG; Pittman QJ
    Epilepsia; 2005 Dec; 46(12):1906-13. PubMed ID: 16393156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat.
    Stroemer RP; Rothwell NJ
    J Cereb Blood Flow Metab; 1997 Jun; 17(6):597-604. PubMed ID: 9236716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin 1 alpha and beta, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides.
    Eriksson C; Nobel S; Winblad B; Schultzberg M
    Cytokine; 2000 May; 12(5):423-31. PubMed ID: 10857755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health.
    Matsukawa A; Fukumoto T; Maeda T; Ohkawara S; Yoshinaga M
    Cytokine; 1997 May; 9(5):307-15. PubMed ID: 9195129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin-1 beta, interleukin-1 receptor antagonist mRNA expression of peripheral blood mononuclear cells (PBMC) in idiopathic nephrotic syndrome (INS) detected by biotin-labelled probe in situ hybridization].
    Liu X; Yang J; Wang S
    Zhonghua Yi Xue Za Zhi; 1995 Mar; 75(3):152-4, 190. PubMed ID: 7780821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain.
    Ali C; Nicole O; Docagne F; Lesne S; MacKenzie ET; Nouvelot A; Buisson A; Vivien D
    J Cereb Blood Flow Metab; 2000 Jun; 20(6):956-66. PubMed ID: 10894179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attenuation of reperfusion injury in the mouse transfected interleukin-1 receptor antagonist].
    Mao Y; Zhou L; Yang G
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):698-701. PubMed ID: 11798839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
    Carl VS; Gautam JK; Comeau LD; Smith MF
    J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain.
    Betz AL; Yang GY; Davidson BL
    J Cereb Blood Flow Metab; 1995 Jul; 15(4):547-51. PubMed ID: 7790404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist.
    Butcher C; Steinkasserer A; Tejura S; Lennard AC
    J Immunol; 1994 Jul; 153(2):701-11. PubMed ID: 8021506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.